Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function

Exclusion Criteria

• •The use of weight-lowering drugs, any investigational blood-glucose or lipid-lowering agent (other than statins or ezetimibe) within the past 3 months
• •Previous treatment with systemic corticosteroids or a change in dosage of thyroid hormones in the previous 6 weeks
• •The use of insulin within the 3 months prior to screening
• •Others